Medina Baking and Powder Products, Inc.
Letter data
- Company
- Medina Baking and Powder Products, Inc.
- Recipient
- Mr. Roberto Martin | President | Medina Baking and Powder Products, Inc. | 1864 NW 22nd Street | Miami | , | FL | 33142-7444 | United States | rmartin@medinabaking.com
- Issue date
- 2024-01-10
- Posted date
- Not available
- FDA office
- Office of Human and Animal Food Operations Division IV East
- Subject
- Not available
- Product
- Dietary Supplements
- CMS ID
- 619373
- Reference number
- 24-HAFE4-WLCOL-01
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Medina Baking and Powder Products, Inc.
MARCS-CMS 619373 —
January 10, 2024
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
VIA Electronic Mail
Reference #:
24-HAFE4-WLCOL-01
Product:
Dietary Supplements
Recipient:
Recipient Name
Mr. Roberto Martin
Recipient Title
President
Medina Baking and Powder Products, Inc.
1864 NW 22nd Street
Miami
,
FL
33142-7444
United States
rmartin@medinabaking.com
Issuing Office:
Office of Human and Animal Food Operations Division IV East
United States
Secondary Issuing Offices
United States
Dear Mr. Roberto Martin:
The Food and Drug Administration has completed evaluation of your firm’s corrective actions in response to our Warning Letter, 22-HAFE4-WL-03 dated March 4, 2022. Based on our evaluation It appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Pearl E. Lopina -S
Pearl Lopina
Digitally signed by Pearl
E. Lopina -S Date: 2024.01.10
14:35:33 -05'00'
Director of Compliance Branch OHAFO, Division IV East
Content current as of:
01/12/2024
Regulated Product(s)
Dietary Supplements